Search
Helping Pharma White Paper
-
Ipsos Update – July 2024
AI, Refugees, Crime … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
A Dose of Digital: Can Pharma Make DTx a Healthy Business?
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
-
ESG in life sciences as a hidden driver for brand success
There is a growing belief among the public that private corporations should also take responsibility for environmental, social, and governance (ESG) issues; these factors are no longer solely the responsibility of the public and governments. While certain business sectors are perceived as having a heightened obligation to diminish their environmental footprint (particularly energy companies, automobile manufacturers, airlines, and public transport providers), no industry can evade the necessity to act responsibly. -
Listen to us - A selection of Ipsos' finest podcasts
Our experts and their guests chat about culture, emerging trends, product innovation, customer experience and much more.
-
Monitoring the obesity treatment revolution, in healthcare and beyond
Ipsos has launched three new syndicated studies to monitor and anticipate changes in the rapidly evolving landscape of obesity treatment.
-
The doctor-patient relationship in the generative AI era
Five reasons why the time to act for pharma is now.
-
A guide to better pharma demand research
Discover the three essential steps for optimizing the quality and reliability of demand research.
-
Ipsos Update - February 2023
Luxury, generation Z, the war in Ukraine… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos teams around the world.
-
Pharma knocks tech off the top spot as most trusted industry in Ipsos' latest global report on Trust
Business leaders are not trusted to tell the truth – yet are seen to have a responsibility to speak out on issues according to the new Ipsos Global Trustworthiness Monitor report.